These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20405183)

  • 1. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.
    Maddur MS; Othy S; Hegde P; Vani J; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Clin Immunol; 2010 May; 30 Suppl 1():S4-8. PubMed ID: 20405183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
    Ephrem A; Chamat S; Miquel C; Fisson S; Mouthon L; Caligiuri G; Delignat S; Elluru S; Bayry J; Lacroix-Desmazes S; Cohen JL; Salomon BL; Kazatchkine MD; Kaveri SV; Misra N
    Blood; 2008 Jan; 111(2):715-22. PubMed ID: 17932250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.
    Tjon AS; Tha-In T; Metselaar HJ; van Gent R; van der Laan LJ; Groothuismink ZM; te Boekhorst PA; van Hagen PM; Kwekkeboom J
    Clin Exp Immunol; 2013 Aug; 173(2):259-67. PubMed ID: 23607448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.
    Ramakrishna C; Newo AN; Shen YW; Cantin E
    PLoS Pathog; 2011 Jun; 7(6):e1002071. PubMed ID: 21655109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.
    Trinath J; Hegde P; Sharma M; Maddur MS; Rabin M; Vallat JM; Magy L; Balaji KN; Kaveri SV; Bayry J
    Blood; 2013 Aug; 122(8):1419-27. PubMed ID: 23847198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
    Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?
    Lan Q; Fan H; Quesniaux V; Ryffel B; Liu Z; Zheng SG
    J Mol Cell Biol; 2012 Feb; 4(1):22-8. PubMed ID: 22107826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
    Galeotti C; Kaveri SV; Bayry J
    Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.
    Ravindranath MH
    J Immunol Res; 2017; 2017():3475926. PubMed ID: 28634589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of immune regulation by IVIG.
    Ballow M
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulin.
    Mouthon L; Piketty C; Kazatchkine MD
    Vox Sang; 1994; 67 Suppl 3():53-9. PubMed ID: 7975512
    [No Abstract]   [Full Text] [Related]  

  • 20. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin.
    Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV
    Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.